Concepedia

Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study

Juan J. Gómez‐Reino, José Ramón Maneiro, Jorge Rodríguez Ruiz, Rosa Roselló, Raimón Sanmartí, Ana Belén Romero

Annals of the Rheumatic Diseases · 2012 · 79 citations · 7 references

Open access

References

7

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

Ralph B. D’Agostino · Statistics in Medicine · 1998 · 5.4K citations

Public Health, Biostatistics, Causal Inference +16

Linear Mixed Models in Practice: A SAS-Oriented Approach

Russell V. Lenth, Geert Verbeke, Geert Molenberghs · Journal of the American Statistical Association · 1998 · 487 citations

Public Health, Biostatistics, Epidemiologic Methods +16

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents

Axel Finckh, Adrian Ciurea, Laure Brulhart et al. · Arthritis & Rheumatism · 2007 · 210 citations

Life Sciences, Immunology, Internal Medicine +14

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

Axel Finckh, Adrian Ciurea, Laure Brulhart et al. · Annals of the Rheumatic Diseases · 2009 · 171 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology.

Frederick Wolfe, Marissa Lassere, D. van der Heijde et al. · PubMed · 1999 · 139 citations

Medicine, Clinical Sciences, Clinical Epidemiology +13